TCL Archive Reinventing NCI: Prevention Program Lacks Leadership, Reorganization Needed, Advisory Group Says June 20, 1997
TCL Archive Letter to the Editor: Could Managed care Cause Drop In Accrual In Suramin Trial? January 5, 1996
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
